Louisiana Attorney General Liz Murrill has filed a motion in the U.S. Court of Appeals for the Fifth Circuit seeking to halt a Biden-era rule that removed a longstanding in-person dispensing requirement for the abortion drug mifepristone.
The motion asks the court to issue a stay or injunction pending appeal as the legal challenge moves forward.
“I have asked the Fifth Circuit to stay the Biden Administration’s unlawful removal of the in-person dispensing requirement for mifepristone,” said Attorney General Murrill. “As the district court concluded, Louisiana is likely to win this case and is suffering irreparable harm. Louisiana will always stand for life.”
The filing follows a decision from the U.S. District Court for the Western District of Louisiana, which found that Louisiana is likely to succeed on the merits of its claims. The State argues that federal agencies acted unlawfully in loosening safety restrictions governing the distribution of mifepristone.
Attorney General Murrill emphasized that the State is seeking immediate relief to prevent further harm while the appellate court considers the case. According to recent data, mifepristone is being used to kill approximately 1,000 unborn Louisiana children each month, with doctors in states like New York and California prescribing and mailing the drug into pro-life states like Louisiana, where abortion is restricted or prohibited.
Read the Motion to Stay brief here.
